Clinical Trial Update: APOLLO(Aromatase Inhibitor Patient cOmpLiance Program With qoL Questionaire)

View source ↗

Summary

Update on the APOLLO study, a patient compliance program for aromatase inhibitors including a quality-of-life questionnaire, in breast cancer; the trial is comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Aromatase inhibitors (aromatase inhibitor)

Snippet

Sponsor: AstraZeneca | Conditions: Breast Cancer | Status: COMPLETED